We observed variability in the degree to which PRC2 inhibition alone induced MHC-I gene expression in individual neuroendocrine tumor lines, which may in part reflect low basal expression of IRF1 and NF-κB components in these malignancies (van 't Veer et al., 1993). This evidence concerns the gene IRF1 and neuroendocrine neoplasm.